Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma
Background: Glioblastoma (GBM) harbors significant genetic heterogeneity, high infiltrative capacity, and patterns of relapse following many therapies. The expression of nuclear factor kappa-B (NF-κB p65 (RelA)) and signaling pathways is constitutively activated in GBM through inflammatory stimulati...
Main Authors: | Hina Ahsan, Shaukat Iqbal Malik, Fawad Ali Shah, Hamed A. El-Serehy, Amin Ullah, Zafar Abbas Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/20/6683 |
Similar Items
-
Hepatotoxicity induced by celecoxib and amlodipine
by: P Zinsser, et al.
Published: (2004-04-01) -
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
by: Cyril Sobolewski, et al.
Published: (2021-07-01) -
Evaluation of Celecoxib-Lactose Incompatibility Reactions at Solid State using Physicochemical Methods
by: Ali Fattahzadeh, et al.
Published: (2021-12-01) -
Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01) -
Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations
by: Ali Attiq, et al.
Published: (2018-06-01)